Adaptimmune Therapeutics PLC (ADAP)
0.8976
-0.10
(-9.71%)
USD |
NASDAQ |
Apr 18, 16:00
0.8926
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Cash and Short Term Investments (Quarterly): 146.94M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 146.94M |
| September 30, 2023 | 161.73M |
| June 30, 2023 | 204.71M |
| March 31, 2023 | 165.55M |
| December 31, 2022 | 204.60M |
| September 30, 2022 | 199.67M |
| June 30, 2022 | 258.09M |
| March 31, 2022 | 304.22M |
| December 31, 2021 | 369.58M |
| September 30, 2021 | 240.12M |
| June 30, 2021 | 285.37M |
| March 31, 2021 | 317.94M |
| December 31, 2020 | 368.22M |
| September 30, 2020 | 399.91M |
| June 30, 2020 | 418.99M |
| March 31, 2020 | 196.43M |
| December 31, 2019 | 89.54M |
| September 30, 2019 | 102.86M |
| Date | Value |
|---|---|
| June 30, 2019 | 133.41M |
| March 31, 2019 | 168.16M |
| December 31, 2018 | 205.13M |
| September 30, 2018 | 237.73M |
| June 30, 2018 | 129.03M |
| March 31, 2018 | 161.83M |
| December 31, 2017 | 208.26M |
| September 30, 2017 | 231.86M |
| June 30, 2017 | 220.02M |
| March 31, 2017 | 203.67M |
| December 31, 2016 | 181.47M |
| September 30, 2016 | 187.50M |
| June 30, 2016 | 205.92M |
| March 31, 2016 | 226.10M |
| September 30, 2015 | 271.91M |
| December 31, 2014 | 126.24M |
| June 30, 2014 | 51.27M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.54M
Minimum
Dec 2019
418.99M
Maximum
Jun 2020
240.41M
Average
204.71M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.593M |
| NuCana PLC | 21.94M |
| Autolus Therapeutics PLC | 239.57M |
| Mereo BioPharma Group PLC | 57.42M |
| TC BioPharm (Holdings) PLC | 3.137M |